Unravelling the Belgian cascade of hypertension care and its determinants: insights from a cross-sectional analysis
- PMID: 38872180
- PMCID: PMC11177511
- DOI: 10.1186/s12889-024-19010-x
Unravelling the Belgian cascade of hypertension care and its determinants: insights from a cross-sectional analysis
Abstract
Background: Hypertension is a major risk factor for cardiovascular disease and all-cause mortality worldwide. Despite the widespread availability of effective antihypertensives, blood pressure (BP) control rates remain suboptimal, even in high-income countries such as Belgium. In this study, we used a cascade of care approach to identify where most patients are lost along the continuum of hypertension care in Belgium, and to assess the main risk factors for attrition at various stages of hypertension management.
Methods: Using cross-sectional data from the 2018 Belgian Health Interview Survey and the Belgian Health Examination Survey, we estimated hypertension prevalence among the Belgian population aged 40-79 years, and the proportion that was (1) screened, (2) diagnosed, (3) linked to care, (4) in treatment, (5) followed up and (6) well-controlled. Cox regression models were estimated to identify individual risk factors for being unlinked to hypertension care, untreated and not followed up appropriately.
Results: The prevalence of hypertension based on self-reported and measured high BP was 43.3%. While 98% of the hypertensive population had their BP measured in the past 5 years, only 56.7% were diagnosed. Furthermore, 53.4% were linked to care, 49.8% were in treatment and 43.4% received adequate follow-up. Less than a quarter (23.5%) achieved BP control. Among those diagnosed with hypertension, males, those of younger age, without comorbidities, and smokers, were more likely to be unlinked to care. Once in care, younger age, lower BMI, financial hardship, and psychological distress were associated with a higher risk of being untreated. Finally, among those treated for hypertension, females, those of younger age, and without comorbidities were more likely to receive no adequate follow-up.
Conclusion: Our results show that undiagnosed hypertension is the most significant barrier to BP control in Belgium. Health interventions are thus needed to improve the accurate and timely diagnosis of hypertension. Once diagnosed, the Belgian health system retains patients fairly well along the continuum of hypertension care, yet targeted health interventions to improve hypertension management for high-risk groups remain necessary, especially with regard to improving treatment rates.
Keywords: Awareness; Blood pressure; Cascade of care; Control; Hypertension; Prevalence; Risk factors; Socioeconomic determinants; Treatment.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures
Similar articles
-
The state of hypertension care in 44 low-income and middle-income countries: a cross-sectional study of nationally representative individual-level data from 1·1 million adults.Lancet. 2019 Aug 24;394(10199):652-662. doi: 10.1016/S0140-6736(19)30955-9. Epub 2019 Jul 18. Lancet. 2019. PMID: 31327566
-
Hypertension care cascade in Chile: a serial cross-sectional study of national health surveys 2003-2010-2017.BMC Public Health. 2020 Sep 14;20(1):1397. doi: 10.1186/s12889-020-09483-x. BMC Public Health. 2020. PMID: 32928176 Free PMC article.
-
Antihypertensive treatment in a general uncontrolled hypertensive population in Belgium and Luxembourg in primary care: Therapeutic inertia and treatment simplification. The SIMPLIFY study.PLoS One. 2021 Apr 5;16(4):e0248471. doi: 10.1371/journal.pone.0248471. eCollection 2021. PLoS One. 2021. PMID: 33819268 Free PMC article.
-
Gender differences in hypertension awareness, antihypertensive use and blood pressure control in Nepalese adults: findings from a nationwide cross-sectional survey.J Biosoc Sci. 2020 May;52(3):412-438. doi: 10.1017/S0021932019000531. Epub 2019 Aug 30. J Biosoc Sci. 2020. PMID: 31466532
-
The cascade of care in managing hypertension in the Arab world: a systematic assessment of the evidence on awareness, treatment and control.BMC Public Health. 2020 Jun 3;20(1):835. doi: 10.1186/s12889-020-08678-6. BMC Public Health. 2020. PMID: 32493255 Free PMC article.
Cited by
-
Scale-Up of Integrated Care Interventions for Chronic Diseases in Diverse Settings.Int J Integr Care. 2024 Sep 10;24(3):19. doi: 10.5334/ijic.8981. eCollection 2024 Jul-Sep. Int J Integr Care. 2024. PMID: 39280803 Free PMC article. No abstract available.
-
Development of quality indicators for hypertension, extractable from the electronic health record of the general practitioner: a rand-modified Delphi method.BMC Prim Care. 2024 Aug 15;25(1):305. doi: 10.1186/s12875-024-02543-w. BMC Prim Care. 2024. PMID: 39148044 Free PMC article.
-
Hypertension Cascade Across Three Healthcare Systems and in Relation to the Level of Implementation of the Integrated Care Package.Int J Integr Care. 2025 Aug 22;25(3):22. doi: 10.5334/ijic.8921. eCollection 2025 Jul-Sep. Int J Integr Care. 2025. PMID: 40862009 Free PMC article.
References
-
- Murray CJL, Aravkin AY, Zheng P, Abbafati C, Abbas KM, Abbasi-Kangevari M, et al. Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the global burden of Disease Study 2019. Lancet. 2020;396(10258):1223–49. doi: 10.1016/S0140-6736(20)30752-2. - DOI - PMC - PubMed
-
- Zhou B, Danaei G, Stevens GA, Bixby H, Taddei C, Carrillo-Larco RM, et al. Long-term and recent trends in hypertension awareness, treatment, and control in 12 high-income countries: an analysis of 123 nationally representative surveys. Lancet. 2019;394(10199):639–51. doi: 10.1016/S0140-6736(19)31145-6. - DOI - PMC - PubMed
-
- Zhou B, Carrillo-Larco RM, Danaei G, Riley LM, Paciorek CJ, Stevens GA, et al. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. 2021;398(10304):957–80. doi: 10.1016/S0140-6736(21)01330-1. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous